Exagen, Inc. (XGN)
4.27
+0.44
(+11.49%)
USD |
NASDAQ |
May 21, 16:00
4.37
+0.10
(+2.34%)
After-Hours: 19:59
Exagen Research and Development Expense (TTM) : 6.523M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Veracyte, Inc. | 79.31M |
| Insight Molecular Diagnostics, Inc. | 16.63M |
| bioAffinity Technologies, Inc. | 2.267M |
| GRAIL, Inc. | 185.25M |
| FONAR Corp. | 1.771M |